NPR  Dec 23  Comment 
The controversy over Turing Pharmaceuticals is just one example. And the results for patients can be devastating.
Financial Times  Nov 25  Comment 
Military personnel suspended after ‘avoidable human error’ in Kunduz air strike on MSF facility
FiercePharma  Nov 3  Comment 
Doctors Without Borders (MSF) often has a bone to pick with Big Pharma, especially when it comes to the industry's patents on expensive life-extending meds. As part of its latest tirade, the group is urging the South African government to override...
Forbes  Oct 22  Comment 
MSF nurse Kaci Hickox was detained against her will last year on the order of Governor Chris Christie (NJ). She was initially held at the airport on arriving back to the United States after caring for patients with Ebola in Sierra Leone. She was...
NPR  Oct 9  Comment 
Jason Cone, executive director of the aid group, talks about the impact of the bombing on his staff — and on the people of Afghanistan.
Financial Times  Oct 5  Comment 
Medical aid group disputes Afghan officials’ claims over bombing
Reuters  Jun 21  Comment 
Disruption of fuel supplies due to fighting between rebel groups in northern Syria is threatening the closure of hospitals and paralysing the work of ambulances and rescue services, an international medical charity said on Sunday.
FiercePharma  Jun 15  Comment 
Western drugmakers have long struggled with India's populist attitude toward patents, but hoped there would be some light at the end of the tunnel with the latest spate of trade negotiations over generic drugs in the country. But Doctors Without...
Reuters  Jun 11  Comment 
Charity Medecins Sans Frontieres appealed to India on Thursday not to give in to pressure from Europe, the United States and Japan to make it easier for big firms to get patents in the country, potentially blocking the production of cheap generics.


Morgan Stanley Emerging Markets Fund, Inc. (MSF)

Closed-end investment companies like the Morgan Stanley Emerging Markets Fund, Inc. do not continuously offer shares to the public. Growth results from market appreciation, which benefits its shareholders. Wide dispersion that results from global diversification, reduces volatility, which gives the shareholder greater safety.

The Emerging Markets Equity team consists of portfolio managers and analysts, headed by James Cheng, and, Ana Cristina Piedrahita. The fund compares its performance to, the Morgan Stanley Capital International (MSCI) Emerging Markets Index, also run by Morgan Stanley. An emerging country as used by the company, is any country that The World Bank or similar major financial institution has determined to have a low or middle economy, or countries included in their own Index.

Shares of Morgan Stanley Emerging Markets Fund, Inc. (MSF) is traded on the New York Stock Exchange under the symbol “MSF.” Its investment objective is long-term capital appreciation through investments primarily in emerging country equity securities. The Fund may invest its assets in foreign real estate companies. It invests in industries, such as commercial banks, wireless telecommunication services, oil, gas and consumable fuels, insurance, pharmaceuticals, electric utilities, tobacco and semiconductors and semiconductor equipment. The Fund invests in the Morgan Stanley Institutional Liquidity Funds-Money Market Portfolio (the Liquidity Funds), a mutual fund managed by the Adviser. The Fund invests in Morgan Stanley Growth Fund, a mutual fund advised by an affiliate of the Adviser. As a result, the Fund and its stockholders, in effect, may be absorbing duplicate levels of fees with respect to investments in mutual funds. The Templeton Russia Fund (TRF) distributes essentially all of its realized income, and capital gains to shareholders each year.

The only other emerging market closed-end fund on the NYSE, is the older Templeton Emerging Markets Fund (NYSE: EMF) [1]

Mark Mobius "World Outlook 2010" [2]

Morgan Stanley Investment Management Inc. 522 Fifth Avenue New York, New York 10036 [3]


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki